Nasopharyngeal carcinoma (or NPC) is a rare type of cancer affecting the epithelial tissue of the nasopharynx, the upper part of the throat behind the nasal cavity. Among the three main subtypes of NPC, non-keratinizing undifferentiated ...
Mar 26, 2024
0
21
According to the American Journal of Roentgenology (AJR), using a 6-mm threshold, rather than a 5-mm threshold, helps facilitate better risk stratification and treatment decisions in patients with nasopharyngeal carcinoma ...
Sep 29, 2023
0
1
Research led by the Sun Yat-sen University Cancer Center in China has highlighted genetic risks for nasopharyngeal carcinoma. In a paper titled "High-throughput identification of regulatory elements and functional assays ...
Nasopharyngeal carcinoma (NPC) is a type of cancer that occurs in the nasopharynx, which is located behind the nose and above the back of the throat. NPC has a geographically skewed distribution worldwide, with high incidence ...
Jun 7, 2023
0
2
A new study published in OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates ...
Mar 27, 2023
0
6
Nasopharyngeal carcinoma (NPC) is the most common malignant tumor of the head and neck in Southeast Asia and Southern China and originates from the epithelial tissue of the nasopharynx. Most NPCs are non-keratinizing cancers, ...
May 27, 2022
0
1
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergized with radiotherapy can control nasopharyngeal carcinoma (NPC) by ...
May 18, 2022
0
9
Nasopharyngeal carcinoma, NPC, is a rare tumor of the head and neck, which originates in the nasopharynx at the very back of the nose. NPC has a particularly high incidence in southern China, Southeast Asia, and North and ...
Nov 2, 2021
0
1
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumors caused by ...
May 11, 2020
0
8
(HealthDay)—Analysis of Epstein-Barr virus (EBV) DNA in plasma samples can identify early asymptomatic nasopharyngeal carcinoma, according to a study published in the Aug. 10 issue of the New England Journal of Medicine.
Aug 10, 2017
0
38
